Data as of Dec 19
| -0.315 / -0.73%|
The 17 analysts offering 12-month price forecasts for Novozymes A/S have a median target of 44.44, with a high estimate of 53.11 and a low estimate of 36.78. The median estimate represents a +3.09% increase from the last price of 43.11.
The current consensus among 18 polled investment analysts is to Hold stock in Novozymes A/S. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.